Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/20/2025

Chapter Title: Diagnostic Imaging of Cytomegalovirus Encephalitis

Introduction to Cytomegalovirus Encephalitis

  • The American Academy of Neurology recommends distinguishing cytomegalovirus (CMV) encephalitis from other viral encephalitis, such as herpes simplex virus (HSV) encephalitis, which predominantly affects temporal lobes, cingulate gyrus, and insular region with gyral edema and possible hemorrhage, and varicella-zoster virus (VZV) encephalitis, which presents with large vessel vasculopathy and ischemic or hemorrhagic infarcts 1

Diagnostic Imaging

  • Magnetic Resonance Imaging (MRI) is significantly more sensitive than Computed Tomography (CT) for detecting cerebral changes in viral encephalitis, with MRI abnormalities found in approximately 90% of patients with viral encephalitis within 48 hours of hospital admission 1
  • The Infectious Diseases Society of America recommends that MRI, including diffusion sequences, should be performed as soon as possible in all patients with suspected encephalitis, ideally within 24 hours of hospital admission 1
  • If the patient's condition prevents MRI, an urgent CT scan can exclude structural causes of elevated intracranial pressure 1

Characteristics of CMV Encephalitis on MRI

  • CMV encephalitis is characterized by periventricular involvement, with hyperintensity on T2 and FLAIR sequences, ependymal and periventricular enhancement, and possible focal lesions in the hippocampus, basal ganglia, and brainstem 1

Patient Population

  • CMV encephalitis primarily occurs in immunocompromised patients, including those with HIV/AIDS, transplant recipients, and patients on immunosuppressive therapy 1

Treatment and Outcome

  • Early identification of radiological findings is crucial for initiating prompt treatment with ganciclovir, foscarnet, or cidofovir, which can significantly improve prognosis in these patients 1
  • The strength of evidence for the effectiveness of these treatments is based on clinical studies, with a moderate to high level of evidence supporting their use 1